Get started
Author

Matteo Ruggeri

Observed names: M Matteo Ruggeri, M Ruggeri, M. Ruggeri, MATTEO RUGGERI, Matteo Ruggeri,, Ruggeri M, Ruggeri Matteo, Ruggeri, Matteo
ORCID: 0000-0002-5703-7424
Observed ORCID: 0000-0002-5703-7424
OpenAlex ID: A5003585738
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
2018 · Paolo Caraceni, Oliviero Riggio, et al. · The Lancet · 558
PDF
The minimum clinically important difference for EQ-5D index: a critical review
2014 · Silvia Coretti, Matteo Ruggeri, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 355
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
2010 · Mario Tumbarello, Teresa Spanu, et al. · Antimicrobial Agents and Chemotherapy · 231
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C
2013 · Calogero Cammà, Salvatore Petta, et al. · Journal of Hepatology · 109
Telemedicine as technoinnovation to tackle COVID-19: A bibliometric analysis
2021 · Carlo Drago, Andrea Gatto, et al. · Technovation · 84
PDF
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study
2018 · Luisa Guidi, Daniela Pugliese, et al. · Journal of Crohn s and Colitis · 83
On the Frontline—A bibliometric Study on Sustainability, Development, Coronaviruses, and COVID-19
2022 · Andrea Gatto, Carlo Drago, et al. · Environmental Science and Pollution Research · 50
PDF
Is risk attitude outcome specific within the health domain?
2007 · Marjon van der Pol, Matteo Ruggeri · Journal of Health Economics · 49
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
2012 · Matteo Ruggeri · Risk Management and Healthcare Policy · 42
PDF
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain
2014 · Flaminia Coluzzi, Matteo Ruggeri · Current Medical Research and Opinion · 38
Economic Assessment of an Anti-HCV Screening Program in Italy
2013 · Matteo Ruggeri, Silvia Coretti, et al. · Value in Health · 38
Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy
2018 · Matteo Ruggeri, Michele Basile, et al. · Journal of Medical Economics · 34
PDF
Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document.
2016 · Marco Marietta, Massimo Franchini, et al. · PubMed · 34
Use of robot‐specific resources and operating room times: the case of Telelap Alf‐X robotic hysterectomy
2016 · Cristiano Rossitto, Salvatore Gueli Alletti, et al. · International Journal of Medical Robotics and Computer Assisted Surgery · 33
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
2017 · Loreta A. Kondili, Federica Romano, et al. · Hepatology · 32
PDF
The cost effectiveness of Botox in Italian patients with chronic migraine
2014 · M. Ruggeri · Neurological Sciences · 30
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.
2016 · Americo Cicchetti, Alexandra Berrino, et al. · PubMed · 28
Multi–Criteria–Decision–Analysis (MCDA) for the Horizon Scanning of Health Innovations an Application to COVID 19 Emergency
2020 · Matteo Ruggeri, Chiara Cadeddu, et al. · International Journal of Environmental Research and Public Health · 25
PDF
Burden of COVID-19 on Italian Internal Medicine Wards: Delphi, SWOT, and Performance Analysis after Two Pandemic Waves in the Local Health Authority “Roma 6” Hospital Structures
2021 · Filomena Pietrantonio, Francesco Rosiello, et al. · International Journal of Environmental Research and Public Health · 24
PDF
Timeline of Authorization and Reimbursement for Oncology Drugs in Italy in the Last 3 Years
2017 · Mariangela Prada, Matteo Ruggeri, et al. · Medicine Access Point of Care · 23
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults
2013 · Matteo Ruggeri, Marco Oradei, et al. · Clinical Drug Investigation · 23
PDF
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature
2015 · Matteo Ruggeri, Silvia Coretti, et al. · Risk Management and Healthcare Policy · 22
PDF
Effectiveness of Pre-Hospital Tourniquet in Emergency Patients with Major Trauma and Uncontrolled Haemorrhage: A Systematic Review and Meta-Analysis
2021 · Roberto Latina, Laura Iacorossi, et al. · International Journal of Environmental Research and Public Health · 20
PDF
Estimating the fiscal impact of three vaccination strategies in Italy
2020 · Matteo Ruggeri, Eugenio Di Brino, et al. · International Journal of Technology Assessment in Health Care · 19
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs
2015 · Valentina Valentina Orlando, Enrica Menditto, et al. · ClinicoEconomics and Outcomes Research · 19
PDF
Works count: 158
Citation count: 2,504
H-index: 22
I10-index: 47
Year
Topic
Type